Norsk mal: Startside

A new National Strategy for Biotechnology in NorwayMinister of Research and Higher Education

Tora AaslandOslo University Hospital, October 11 2011

Why a National Strategy on Biotechnology?

foto: Colourbox.no

2

FUGE is Ending – What Now?

?

3

FUGE has Improved Norwegian Life Science Research

19901991

19921993

19941995

19961997

19981999

20002001

20022003

20042005

20062007

20082009

0

500

1000

1500

2000

2500

DanmarkFinlandNorgeSveitsSverige

Cha

nge

in n

umbe

r of

publ

icati

ons,

rela

tive

to y

ear

1990

DamVad – FUGE evaluation 2011

4

Financial Support of Public Institutions

NIFU – Rapport om Bioteknologi 2011

International

EU

Industry

Others

Norwegian Research Council

Institutions

0 100 200 300 400 500 600 700 800 900

2009 2007 2005

2003

Mill. kr

5

Overview of the New StrategyAquaculture, Seafood and

Marine Biotechnology

Healthcare

International cooperation

Knowledge and Infrastructure

Business development

Agriculture and Biomass

Environmental- friendly Industrial

Processes and Energy

Biotechnology and Society

6

Primary Production and Industry

foto: Kyrre Lien

7

Illustrasjonsfoto: Colourbox.no

Thematic Healthcare

foto: Colourbox.no foto: Hunt Bioscience

8

Overarching Areas

foto: Colourbox.no

foto: Hunt Bioscience

9

A Strategic Change in How we Fund Biomedical Research

Non-thematic Grants Infrastructure

New Biotechnology

Program

10

11